Clinical Presentation and Follow Up of Patients with Mucopolysaccharidosis Type IVA (Morquio A Disease): Single Center Experience

Journal Title: The Journal of Pediatric Research - Year 2018, Vol 5, Issue 1

Abstract

Aim: Mucopolysaccharidosis Type IVA (MPS IVA), Morquio A, is caused by the deficiency in lysosomal enzyme N-acetylgalactosamine-6-sulfate sulfatase. Multisystemic involvements include skeletal systems, pulmonary disease, valvular heart disease, hearing loss, mild hepatomegaly, corneal clouding, coarse facial features. Materials and Methods: We retrospectively analyzed clinical and laboratory and follow up findings of our 25 patients with ministry for primary industries independent verification agency. Results: Mean age of the patients was 14.9±7.05 (5.5-36 years). Mean age at diagnosis was 7.3±6.2 years (6 months-31 years). Female: male ratio was 13/12. All patients had skeletal manifestation and X-ray analysis demonstrated “dysostosis multiplex”. Twelve patients (48%) had cardiac valve disease. Twenty three (92%) patients had corneal clouding, 15 (60%) patients had hearing loss and 9 (36%) had hepatomegaly. Six (24%) patients were unable to walk. Mean follow up period is 7.4 years ±3.5 years (3 months-17 years). Four patients have not visit our clinical for last ≥3 years. Three patients died during follow up. Conclusion: MPS IVA is a severe disorder and is usually fatal in the second or third decade of life due to the complications of the disease. Early diagnosis of the patient became more important, because specific therapy with elasulphase alpha was approved recent years ago.

Authors and Affiliations

Ebru Canda, Havva Yazıcı, Esra Er, Cenk Eraslan, Sema Kalkan Uçar, Mahmut Çoker

Keywords

Related Articles

A New Problem of Adolescents: “Bonsai”

Synthetic cannabinoids have been increasingly used by adolescents in the recent years. In our country, synthetic cannabinoids are known as “bonsai”. They may cause neuropsychiatric effects such as psychosis, agitation, a...

Do We Have to Obtain Rebound Bilirubin Levels and What is the Optimal Time?

Aim: We aimed to determine the frequency of rebound hyperbilirubinemia (RHB) needing treatment and therefrom, to clarify the clinical importance of routinely checking serum total bilirubin (STB) levels after the cessatio...

A Migrated-mesenteric Lymphangioma: An Unusual Case of Intrabdominal Cystic Lesion in a New-born

Abdominal lymphangioma is a rare presentation of abdominal cystic lesions. They generally arise from small bowel mesentery. Migration of abdominal masses is an uncommon entity and usually occurs due to gossypiboma. There...

Lymphadenopathies: An Annoyance or Not?

Aim: The aim of this study was to evaluate the cases hospitalized with lymphadenopathy in terms of demographic and clinical characteristics, lymph node involvement regions, infection markers and their diagnoses. Materia...

A Qualitative Study Exploring the Needs of Turkish Mothers in the Pediatric Intensive Care Unit

Aim: Mothers have different needs, depending on their cultural and religious backgrounds, and these need to be known and acknowledged by the pediatric intensive care unit (PICU) professional staff. To date, limited studi...

Download PDF file
  • EP ID EP382379
  • DOI 10.4274/jpr.52244
  • Views 106
  • Downloads 0

How To Cite

Ebru Canda, Havva Yazıcı, Esra Er, Cenk Eraslan, Sema Kalkan Uçar, Mahmut Çoker (2018). Clinical Presentation and Follow Up of Patients with Mucopolysaccharidosis Type IVA (Morquio A Disease): Single Center Experience. The Journal of Pediatric Research, 5(1), 28-33. https://europub.co.uk/articles/-A-382379